Robitussin owes some cold sufferers money as part of a class-action settlement. The cough medicine brand has agreed to pay $4.5 million to resolve claims that it duped consumers by marketing its ...

The deadline to get money back as part of a $4.5 million class action settlement involving certain Robitussin products is here. Consumers have until May 12, 2025 to sign up to be included in the ...

The settlement ends two lawsuits that claimed that some of the products were “deceptively marketed, advertised, labeled, and sold as `Non-Drowsy,’” but actually contained dextromethorphan, which may ...

Had a chance to navigate the cough and cold aisle of your pharmacy? Good luck getting what you're looking for. And even if you do, it may very well not work. Have you shopped for cough medicine ...

Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.